Accelerating INDs Without Animals: How CROs Can Capitalize on FDA’s New Methodologies
A landmark FDA direct final rule officially clears the path for organs-on-chips and in vitro models. Advanced CROs can capture the shifting outsourcing market
Advertisement
A landmark FDA direct final rule officially clears the path for organs-on-chips and in vitro models. Advanced CROs can capture the shifting outsourcing market
Advertisement
Found a foreign object in the production line? Employ forensic failure analysis to isolate the root cause, satisfy cGMP CAPA requirements, and safely resume operations
With the 2026 Cyclospora outbreak linked to fresh lettuce, learn why this parasite evades traditional swabs and how FDA molecular testing can secure your produce supply chain
Learn why regulatory bodies shifted from PFGE to WGS—and how outsourcing to an accredited contract lab can accelerate contamination investigations
Explore the essential analytical and microbiological laboratory tests to ensure your diluents meet strict USP monographs
Preclinical data is commercially useful only when it adheres to stringent global quality management frameworks
From LADME frameworks to toxicokinetics, discover why PK/PD testing is the critical bridge between preclinical discovery and clinical trial success
Join us and Thermo Fisher's Suja Sukumaran, PhD, to know how FTIR spectroscopy supports material identification, product testing, and regulatory compliance across industries
With global supply chains expanding for repurposed anthelmintic APIs, robust third-party testing is essential to verify compound identity, ensure potency, and maintain strict regulatory compliance
Attendees can connect directly with our expert speakers in the Q&A segment post each session
Join us and Waters' Duanduan Han, PhD, to explore how LC-UV/MS workflow can help labs meet safety and regulatory standards for GLP-1 analogs
Advertisement
Advertisement